Investing.com - GlaxoSmithKline reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline announced earnings per share of £0.366 on revenue of £9.08B. Analysts polled by Investing.com anticipated EPS of £0.2862 on revenue of £8.69B.
GlaxoSmithKline shares are up 7% from the beginning of the year and are trading at £1,436.00 , down-from-52-week-high.They are under-performing the FTSE 100 which is up 12.48% from the start of the year.
GlaxoSmithKline shares gained 0.13% in intra-day trade following the report.
GlaxoSmithKline follows other major Healthcare sector earnings this month
GlaxoSmithKline's report follows an earnings matched by 4D Pharma PLC on Thursday, September 30, 2021, who reported EPS of £-0.0064 on revenue of £231.0K, compared to forecasts EPS of £-0.0064 on revenue of £0.00.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar